Literature DB >> 22315638

Immunohistochemical analysis of a merkeloma observed in a patient affected by hereditary haemorrhagic telangiectasia.

Elisa Rossi1, Laura Boeri, Patrizia Morbini, Fabio Pagella, Andrea Colombo, Elina Matti, Carla Olivieri, Vincenzo Villanacci, Antonella Minelli, Elisabetta Buscarini, Cecilia Canzonieri, Cesare Danesino.   

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by epistaxis, telangiectases, and multiorgan vascular dysplasia. Mutations of the ENG and ACVRL1 genes cause at least 80% of cases. We report the first case of merkeloma found in a patient with HHT carrying an ENG mutation. We analysed the tumour with immunohistochemical methods using primary antibodies against CD105 (endoglin), TGF-β, Smad4, CD31 and CD34. Tumour cells were positive for Smad4, weakly positive for TGF-β, and negative for CD105. Vasal endothelial cells were highly positive for CD105, CD31 and CD34. No remarkable differences between cancer and normal cells in our patient or between the patient's merkeloma and two control merkelomas were observed. The presence of a merkeloma in an HHT patient could be an occasional association, but to certainly assume it further investigations are needed.

Entities:  

Year:  2010        PMID: 22315638      PMCID: PMC3028296          DOI: 10.1136/bcr.09.2009.2251

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin.

Authors:  U Cymerman; S Vera; N Pece-Barbara; A Bourdeau; R I White; J Dunn; M Letarte
Journal:  Pediatr Res       Date:  2000-01       Impact factor: 3.756

Review 2.  Hereditary hemorrhagic telangiectasia.

Authors:  A E Guttmacher; D A Marchuk; R I White
Journal:  N Engl J Med       Date:  1995-10-05       Impact factor: 91.245

Review 3.  Merkel cell carcinoma (neuroendocrine carcinoma of the skin).

Authors:  P D Smith; J W Patterson
Journal:  Am J Clin Pathol       Date:  2001-06       Impact factor: 2.493

Review 4.  Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.

Authors:  S A Abdalla; M Letarte
Journal:  J Med Genet       Date:  2005-05-06       Impact factor: 6.318

5.  Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

Authors:  D W Johnson; J N Berg; M A Baldwin; C J Gallione; I Marondel; S J Yoon; T T Stenzel; M Speer; M A Pericak-Vance; A Diamond; A E Guttmacher; C E Jackson; L Attisano; R Kucherlapati; M E Porteous; D A Marchuk
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

6.  Umbilical vein and placental vessels from newborns with hereditary haemorrhagic telangiectasia type 1 genotype are normal despite reduced expression of endoglin.

Authors:  N L M Chan; A Bourdeau; S Vera; S Abdalla; M Gross; J Wong; U Cymerman; A D Paterson; B Mullen; M Letarte
Journal:  Placenta       Date:  2004 Feb-Mar       Impact factor: 3.481

7.  Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.

Authors:  K A McAllister; K M Grogg; D W Johnson; C J Gallione; M A Baldwin; C E Jackson; E A Helmbold; D S Markel; W C McKinnon; J Murrell
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

8.  Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies.

Authors:  Carla Olivieri; Fabio Pagella; Lucia Semino; Luca Lanzarini; Cristina Valacca; Andrea Pilotto; Sabrina Corno; Susi Scappaticci; Guido Manfredi; Elisabetta Buscarini; Cesare Danesino
Journal:  J Hum Genet       Date:  2007-09-05       Impact factor: 3.172

Review 9.  Novel biochemical pathways of endoglin in vascular cell physiology.

Authors:  Carmelo Bernabeu; Barbara A Conley; Calvin P H Vary
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

10.  Association of hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) and malignant melanoma in two patients.

Authors:  Nicolas Kluger; Sophie Riviére; Isabelle Coupier; Didier Bessis; Bernard Guillot
Journal:  Melanoma Res       Date:  2007-06       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.